Envista Holdings (NVST)

NYSE Health Care Health Care Supplies S&P MidCap 400
$25.17
+0.21 (+0.84%)
Close of Nov 06, 2026 · end-of-day data
SMA 50SMA 2005Y/10Y use weekly candles (10/40-week averages)

Performance

price return
1W+7.1%
1M+10.8%
3M-10.7%
6M+3.8%
YTD+15.9%
1Y+24.9%
3Y+9.5%
5Y-35.6%

Key statistics

Full financials →
Market cap$4.0B
P/E (TTM)6.5
EPS (TTM, diluted)$3.87
P/S1.40
P/B1.31
EV / EBITDA5.1
Revenue (TTM)$2.88B
Revenue growth+9.8%
Net margin22.0%
ROE20.5%
Debt / equity0.46
FCF yield6.0%
Dividend yield—
Payout ratio—
Beta (1Y)1.30
Volatility (1Y)39.9%
52-week range$18.77 – $30.42
Avg volume (50D)3.05M

Revenue & net income — last 8 quarters

Statements →
Nov 4, 4:14 PM ET

Envista raises 2026 EPS guidance as Q3 adjusted EPS rises 25% to $0.40

Positive earnings 2.027.01

Envista reported third-quarter 2026 sales of $691.5 million, up 3.2% from a year earlier, with core sales growth of 2.7%. GAAP diluted EPS was $3.11, compared with a loss of $0.18 a year earlier, but that result includes a non-cash $428 million foreign currency translation gain, while adjusted diluted EPS rose to $0.40 from $0.32. The company raised its full-year 2026 adjusted diluted EPS guidance to $1.54 to $1.58 from $1.50 to $1.55.

  • Q3 sales $691.5 million vs. $669.9 million a year earlier; core sales growth 2.7%
  • GAAP diluted EPS $3.11 includes a $428 million non-cash currency translation gain ($2.62 per diluted share before tax)
  • Adjusted EBITDA $105.8 million, up from $97.1 million; adjusted EBITDA margin 15.3%
  • Updated 2026 guidance: adjusted diluted EPS $1.54 to $1.58 (prior $1.50 to $1.55); adjusted EBITDA growth 12.5% to 14% (prior 11% to 14%)
Read the filing on SEC.gov ↗
Oct 27, 4:37 PM ET

Envista Publishes 2025 Sustainability Report With Waste, Water and Injury Gains

Neutral other 7.01

Envista Holdings announced the publication of its 2025 Sustainability Report, its sixth annual report, covering progress on dental care access, employees, communities, environmental efficiency and governance. The filing is a furnished press release with no financial results, guidance or transaction, so it does not change the company's financial outlook.

  • Waste generation fell 40% year over year in 2025.
  • Water consumption fell 19% year over year in 2025.
  • The Envista Smile Project donated $2.4 million and benefited close to 20,000 patients, and the lost time injury rate fell 17% year over year.
Read the filing on SEC.gov ↗
Aug 19, 8:38 AM ET

Envista Names CEO Paul Keel Chairman; Approves $10 Million Special Equity Award

Neutral leadership Written later 5.028.01

Envista's board named President and CEO Paul Keel as Chair of the Board, effective August 19, 2026, succeeding Scott Huennekens, who becomes Lead Independent Director. The Compensation Committee also approved a $200,000 base salary increase for Keel and a one-time equity award valued at $10 million, plus a $1.5 million PSU award for CFO Eric Hammes, tied to four-year relative total stockholder return.

  • Paul Keel, President and CEO since joining in May 2024, becomes Chair of the Board effective August 19, 2026
  • Keel's base salary rises $200,000, from $1.1 million to $1.3 million per year, effective August 24, 2026
  • Keel's one-time equity award totals $10 million: $5 million in time-based RSUs and $5 million in PSUs at target
  • CFO Eric Hammes received a special PSU award valued at $1.5 million, granted August 18, 2026
Read the filing on SEC.gov ↗
Aug 5, 4:12 PM ET

Envista raises 2026 outlook after second-quarter sales rise 7.1% to $730.5 million

Positive guidance Written later 2.027.01

Envista reported second-quarter 2026 sales of $730.5 million, up 7.1% from a year earlier, and GAAP diluted EPS of $0.33 versus $0.16. The company raised its full-year 2026 guidance for core sales growth, adjusted EBITDA growth and adjusted diluted EPS, which now stands at $1.50 to $1.55 compared with the prior $1.35 to $1.45.

  • Q2 2026 GAAP net income was $53.7 million versus $26.4 million, and adjusted diluted EPS was $0.41 versus $0.26
  • Adjusted EBITDA was $107.7 million, up from $84.3 million, with a 14.7% adjusted EBITDA margin on sales
  • Full-year 2026 adjusted diluted EPS guidance was raised to $1.50 to $1.55 from $1.35 to $1.45; core sales growth guidance rose to 3.5% to 4.5% from 2% to 4%
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Famous investors who own NVST

All investors →
InvestorValue% of portfolioLast quarter
Renaissance Technologies $40.07M0.06% Added
Ray Dalio Bridgewater Associates $1.10M0.00% Reduced

From each investor's latest 13F filing (Q2 2026); positions are as of the quarter end and filed up to 45 days later.

Insider transactions

All insider trades →
DateInsiderTypeSharesPriceValue
Nov 01Keel Paul A
Director, Chairman and CEO
Tax Withholding54.20K$23.51$1.27M

Prices are end-of-day and split-adjusted. Financial data from Envista Holdings's SEC XBRL filings. Not investment advice.